Opinion/Info29 Sep 2018 09:14
Just like to give my opinion and a reply I forgot to post from Sep 19th from Barry the CFO :
Not too dismayed by the fund raise, get that all off and announced on Monday, even at 10p, and we're off and running flat out. Genuine company with genuine products and honest to boot. Don't think the 'going concern' statements are unusual but the honesty in stating further funds will be needed is, so laudable.
Here's the Sep 19th reply I got with briefly my queries :
"The Directors estimate that these payments will be no more than £1m ". Is this in addition to the £2m already paid as costs settled relating to the July 2017 trial?
"Once launched, Premaitha will pay Illumina a royalty per sample tested using the IONA® test based on Illumina sequencing technology". "Premaitha will develop an IONA® test that runs on Illumina sequencing technology, to be launched in early 2020". Does this mean that royalty payments to Illumina will not kick in immediately, not until this new test is up and running in 2020?
Dear pabs
Thanks for your message. Unfortunately we are restricted from disclosing the details of the settlement but I can confirm that today’s announcement does not reflect the £2m paid previously. Similarly, I can confirm that the “up to £1m” covers all costs payable until we launch the new version of the test.
Regards
Barry
.....................
Feel that bit about 'all costs payable until new test' is good news